Above Food Ingredients Inc. (ABVE) 股票分析

公司概述

Above Food Ingredients Inc. operates as a regenerative ingredient company that produces vertically integrated supply chain products across a global footprint spanning Canada, the United States, Mexico, China, France, Turkey, and international markets. The company functions within the Consumer Defensive sector, specifically the Packaged Foods industry, which typically implies a business model focused on providing essential goods with relatively stable demand patterns regardless of economic cycles. Its current market capitalization stands at $40.21M, supported by an annual revenue of $294.84M, while the employee count is not publicly disclosed in the available data. These financial dimensions suggest that the company holds a small-cap status with a significant revenue base, indicating a potential position where operational scale exists but the market valuation remains modest relative to its top-line generation.

财务健康

The company reported revenue of $294.84M over the trailing twelve months, yet it simultaneously recorded a net income loss of $61,292,864 and an EBITDA of $-40,343,004. The substantial gap between the positive revenue figure and the negative net income reveals a challenging cost structure where operating expenses and taxes significantly erode profitability, resulting in a net loss that is more than 1.5 times the magnitude of the EBITDA loss. Regarding free cash flow, this metric is not available in the current reporting period, which limits the ability to assess immediate financial flexibility or the capacity to fund capital expenditures without external financing. The gross margin stands at -2.8%, the operating margin is -23.3%, and the profit margin is -23.4%, all of which indicate that the company is currently generating losses at every level of the income statement, suggesting that unit economics are not yet covering full costs or that the business is in a heavy investment phase. The balance sheet shows a cash balance of $664,430 against total debt of $133.84M, creating a stark contrast where cash on hand is negligible compared to liabilities. Although the debt-to-equity ratio is not disclosed, the disparity between minimal cash and high debt implies a leveraged balance sheet rather than a conservative one. Furthermore, the current ratio is 0.23, which indicates that the company's current assets are less than a quarter of its current liabilities, signaling severe short-term liquidity constraints and potential difficulty in meeting obligations without refinancing or additional capital injection. Return on Equity and Return on Assets are both not available due to the negative equity position or lack of data, preventing a direct assessment of management effectiveness in generating returns on the capital base.

估值评估

The P/E Ratio (TTM) and Forward P/E are both not available, likely due to the negative earnings in the trailing twelve months, which prevents a traditional earnings-based valuation comparison. The price-to-book ratio is -1.83, a negative figure that technically indicates the market values the company below its book value or reflects adjustments for intangible assets and liabilities that result in a negative net asset position. The price-to-sales ratio is 0.14, while the EV/EBITDA is -3.86; these alternative metrics suggest that the market is pricing the stock based on sales volume rather than profitability, often seen in early-stage or turnaround situations where future earnings are expected to materialize later. The 52-week high is $6.56 and the 52-week low is $0.32, placing the current trading price in a wide range that reflects high volatility and significant potential for price movement depending on market sentiment and operational news. The beta is 0.13, which indicates that the stock's price volatility is significantly lower than the broader market, suggesting it behaves more like a defensive asset that does not move in tandem with general market swings.

Growth & Income

Revenue growth year-over-year is -45.0%, while earnings growth year-over-year is not available due to the negative earnings base; the decline in revenue indicates a contraction in sales volume or pricing power rather than growth. Since the company is currently unprofitable, it does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning all available cash is theoretically retained or required for operations rather than distributed to shareholders. Consequently, the company reinvests any remaining liquidity into its regenerative agriculture and ingredient production operations rather than distributing income to investors. The overall growth and income profile is characterized by significant revenue contraction, negative profitability across all margins, and a lack of dividend support, positioning the stock as a speculative vehicle dependent on future operational improvements to restore positive cash flows and earnings.